# Central Garden & Pet Co: Form 10-Q for the period ended Mar 29, 2025

- Company: [Central Garden & Pet Co](/companies/cent.md) (CIK 887733)
- Form: 10-Q
- Filed: 2025-05-08
- Accepted by EDGAR: May 8, 2025, 13:21 ET
- Period: 2025-03-29
- Accession: 0000887733-25-000015
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/887733/000088773325000015/cent-20250329.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/887733/000088773325000015/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-03-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-12-29 to 2025-03-29 | $833.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2024-09-29 to 2025-03-29 | $1.49bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2024-12-29 to 2025-03-29 | $560.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2024-09-29 to 2025-03-29 | $1.02bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2024-12-29 to 2025-03-29 | $273.1m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2024-09-29 to 2025-03-29 | $468.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2024-12-29 to 2025-03-29 | $179.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2024-09-29 to 2025-03-29 | $347.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2024-12-29 to 2025-03-29 | $93.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2024-09-29 to 2025-03-29 | $121.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2024-12-29 to 2025-03-29 | $14.5m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months, 2024-09-29 to 2025-03-29 | $29.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2024-12-29 to 2025-03-29 | $19.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2024-09-29 to 2025-03-29 | $24.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-12-29 to 2025-03-29 | $63.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2024-09-29 to 2025-03-29 | $77.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-12-29 to 2025-03-29 | $0.98 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2024-09-29 to 2025-03-29 | $1.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-12-29 to 2025-03-29 | $0.99 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2024-09-29 to 2025-03-29 | $1.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-12-29 to 2025-03-29 | 64,879,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2024-09-29 to 2025-03-29 | 65,171,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2024-09-29 to 2025-03-29 | −$115.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2024-09-29 to 2025-03-29 | $16.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2024-09-29 to 2025-03-29 | $98.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-03-29 | $516.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-03-29 | $1.98bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-03-29 | $3.63bn | us-gaap:Assets |
| Current liabilities | at 2025-03-29 | $597.7m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2025-03-29 | $1.19bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-03-29 | $122.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2025-03-29 | $1.54bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 50,781 characters.

### Our Company

Central Garden & Pet Company (“Central”) is a market leader in the garden and pet industries in the United States. For over 40 years,

Central has proudly nurtured happy and healthy homes by bringing innovative and trusted solutions to consumers and its customers. We

manage our operations through two reportable segments: Pet and Garden.

Our Pet segment includes dog and cat supplies such as dog treats and chews, toys, pet beds and grooming products, waste

management and training pads, pet containment; supplies for aquatics, small animals, reptiles and pet birds including toys, enclosures and

habitats, bedding, food and supplements; products for equine and livestock, animal and household health and insect control products; live

fish and small animals as well as outdoor cushions. These products are sold under brands such as Aqueon®, Cadet®, C&S®, Comfort

Zone®, Farnam®, Four Paws®, Kaytee®, Nylabone® and Zilla®.

Our Garden segment includes lawn and garden consumables such as grass seed, vegetable, flower and herb packet seed; wild bird

feed, bird houses and other birding accessories; weed, grass, and other herbicides, insecticide and pesticide products; fertilizers and live

plants. These products are sold under brands such as Amdro®, Ferry-Morse®, Pennington® and Sevin®.

In fiscal 2024, our consolidated net sales were $3.2 billion, of which our Pet segment, or Pet, accounted for approximately $1.8 billion

and our Garden segment, or Garden, accounted for approximately $1.4 billion. In fiscal 2024, our operating income was $185 million

consisting of income from our Pet segment of $203 million, income from our Garden segment of $82 million and corporate expenses of $100

million.

We were incorporated in Delaware in May 1992 as the successor to a California corporation that was formed in 1955. Our executive

offices are located at 1340 Treat Boulevard, Suite 600, Walnut Creek, California 94597, and our telephone number is (925) 948-4000. Our

website is www.central.com. The information on our website is not incorporated by reference in this quarterly report.

### Recent Developments

### Fiscal 2025 Second Quarter Financial Performance:

- Net sales decreased $66.6 million, or 7.4%, from the prior year quarter to $834 million, with Pet net sales decreasing

5.5% and Garden net sales decreasing 9.5%.

- Gross profit decreased $5.8 million from the prior year quarter, while gross margin increased 180 basis points to 32.8%.
- Selling, general and administrative expense decreased $5.7 million from the prior year quarter to $179.8 million and

increased as a percentage of net sales 100 basis points to 21.6%.

- Operating income was $93.3 million in the second quarter of fiscal 2025 and was relatively flat as compared to the

second quarter of 2024. On a non-GAAP basis, operating income was $98.7 million in both periods.

- Net Income in the second quarter of fiscal 2025 was $63.6 million, or $0.98 per diluted share, compared to $62.0 million,

or $0.93 per diluted share, in the second quarter of fiscal 2024. On a non-GAAP basis, net income was $67.7 million, or

$1.04 per diluted share, in the second quarter of fiscal 2025.

### Wind-down of U.K. Operations

In March 2025, we decided to wind-down our operations in the United Kingdom, which also served certain European markets, as we

move to a direct-export model. As a result, we incurred approximately $5.3 million of one-time costs, including $4.4 million in cost of goods

sold and $0.9 million in selling, general and administrative costs, related to the liquidation of inventory and receivables. We expect to incur

additional costs, including severance and facility closure costs, in the remaining two quarters of fiscal 2025.

### Stock Repurchases

Since our quarter ended March 29, 2025, through April 30, 2025, we have repurchased 0.8 million shares of our non-voting common

stock (CENTA) and 0.4 million shares of our voting common stock (CENT) on the open market at an aggregate cost of $38.7 million. As of

April 30, 2025, we had approximately $62.5 million remaining under our 2024 Repurchase Authorization.

23

### Results of Operations

### Three Months Ended March 29, 2025

### Compared with Three Months Ended March 30, 2024

### Net Sales

Net sales for the three months ended March 29, 2025, decreased $66.6 million, or 7.4%, to $833.5 million from $900.1 million for the

three months ended March 30, 2024. The decline in net sales was driven in part by the timing of customer orders that shifted sales into the

first quarter. Our branded product sales decreased $44.2 million, and sales of other manufacturers’ products decreased $22.4 million.

Pet net sales decreased $26.5 million, or 5.5%, to $453.7 million for the three months ended March 29, 2025, from $480.2 million for

the three months ended March 30, 2024. The decline in net sales was driven primarily by the timing of customers orders and promotional

events that shifted sales into the first quarter. Pet sales were also negatively impacted by the continued decline in demand for pet durable

products, particularly our outdoor cushion and pet bed business and our aquatics business. Pet branded product sales decreased $28.9

million, and sales of other manufacturers' products increased $2.4 million.

Garden net sales decreased $40.1 million, or 9.5%, to $379.8 million for the three months ended March 29, 2025 from $419.9 million

for the three months ended March 30, 2024. Garden net sales declined due primarily to customers shifting pre-season orders into the first

quarter, unfavorable weather resulting in a delayed start to the garden season and decreased sales of third-party products which were

negatively impacted by the loss of distribution of two product lines. These declines were partially offset by increased sales of our Wild Bird

business due to the colder weather. Garden branded product sales decreased $15.3 million, and sales of other manufacturers' products

decreased $24.8 million.

### Gross Profit

Gross profit for the three months ended March 29, 2025 decreased $5.8 million, or 2.1%, to $273.1 million from $278.9 million for the

three months ended March 30, 2024. The decrease in gross profit was due to lower net sales. Gross margin increased 180 basis points to

32.8% for the three months ended March 29, 2025 from 31.0% for the three months ended March 30, 2024.

Both segments contributed to the improved gross margin, which was driven by productivity gains resulting from our Cost and

Simplicity program (e.g., prior year facility consolidations and the exit of lower margin businesses) and moderating inflation.

On a non-GAAP basis, which excludes the impact of charges for facility closures in the second quarter of fiscal 2025 and fiscal 2024,

non-GAAP gross margin increased 200 basis points to 33.3% for the three months ended March 29, 2025, from 31.3% for the three months

ended March 30, 2024.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased $5.7 million, or 3.1%, to $179.8 million for the three months ended March 29,

2025\. As a percentage of net sales, selling, general and administrative expenses increased to 21.6% for the three months ended March 29,

2025, compared to 20.6% in the comparable prior year quarter due primarily to the decrease in net sales. Selling, general and administrative

expenses decreased in both corporate and Garden, while Pet was relatively flat, as compared to the prior year quarter.

Selling and delivery expense decreased $0.7 million to $81.7 million for the three months ended March 29, 2025 as compared to $82.4

million in the prior year quarter. The decreased expense was in the Garden segment due primarily to lower headcount.

Warehouse and administrative expense decreased $5.0 million, or 4.9%, to $98.1 million for the three months ended March 29, 2025

from $103.1 million for the three months ended March 30, 2024. The decrease in warehouse and administrative expense was primarily in

Garden, due in part to a reduced headcount, although both corporate and Pet also had minor decreases. Corporate expense decreased

$0.3 million due primarily to lower third-party expenses and lower insurance costs. Corporate expenses are included within administrative

expense and relate to the costs of unallocated executive, administrative, finance, legal, human resources, and information technology

functions.

### Operating Income

Operating income decreased $0.1 million, or 0.1%, to $93.3 million for the three months ended March 29, 2025 from $93.4 million for

the three months ended March 30, 2024. Our operating margin increased from 10.4% in the prior year quarter to 11.2% in the current year

quarter. The decrease in operating income was due to reduced net sales partially offset by a 180 basis point increase in gross margin and a

$5.7 million decrease in selling, general and administrative expense.

Pet operating income decreased $2.0 million, or 3.3%, to $60.6 million for the three months ended March 29, 2025 from $62.6 million

for the three months ended March 30, 2024. Pet operating income decreased due to a $26.5 million decline in net sales partially offset by

improved gross margin.

Garden operating income increased $1.7 million to $58.7 million for the three months ended March 29, 2025. Garden operating

income increased due to an improved gross margin and lower selling, general and administrative expenses partially offset by lower net sales.

24

Corporate operating expense decreased $0.3 million, or 1.0%, to $26.0 million for the three months ended March 29, 2025 from $26.3

million for the three months ended March 30, 2024, due primarily to lower third-party expenses and lower insurance costs.

### Net Interest Expense

Net interest expense for the three months ended March 29, 2025 decreased $2.1 million, or 18.4%, to $9.4 million from $11.5 million

for the three months ended March 30, 2024. The decrease in net interest expense was due to increased interest income resulting from higher

cash balances during the current quarter. Debt outstanding on March 29, 2025 was $1,190.8 million compared to $1,189.3 million at March

30, 2024.

### Other Income

Other income is comprised of income or losses from investments accounted for under the equity method of accounting and foreign

currency exchange gains and losses. Other income increased $0.9 million to $0.7 million of income for the three months ended March 29,

2025 from $0.2 million of expense for the three months ended March 30, 2024. The increase in other income was due primarily to foreign

currency gains in the current year quarter as compared to foreign currency losses in the prior year quarter.

### Income Taxes

Our effective income tax rate was 23.5% for the quarter ended March 29, 2025 and 23.4% for the quarter ended March 30, 2024.

### Net Income and Earnings Per Share

Net income in the second quarter of fiscal 2025 was $63.6 million, or $0.98 per diluted share, compared to $62.0 million, or $0.93 per

diluted share, in the second quarter of fiscal 2024. On a non-GAAP basis, net income in the second quarter of fiscal 2025 was $67.7 million,

or $1.04 per diluted share, compared to $66.0 million, or $0.99 per diluted share, in the second quarter of fiscal 2024.

### Six Months Ended March 29, 2025

### Compared with Six Months Ended March 30, 2024

### Net Sales

Net sales for the six months ended March 29, 2025 decreased $45 million, or 2.9%, to $1,490 million from $1,535 million for the six

months ended March 30, 2024. Our branded product sales decreased $23 million, and sales of other manufacturers’ products decreased

$22 million.

Pet net sales decreased $8.2 million, or 0.9%, to $881 million for the six months ended March 29, 2025 from $889 million for the six

months ended March 30, 2024. The decline in Pet net sales was due primarily to lower sales of durable items impacting outdoor cushions,

pet beds and aquatics. Pet branded sales decreased $15 million, and sales of other manufacturer's products increased $7 million.

Garden net sales decreased $36.4 million, or 5.6%, to $609 million for the six months ended March 29, 2025 from $645 million for the

six months ended March 30, 2024. The decline in Garden net sales was due primarily to the loss of two product lines in our third-party

distribution business and unfavorable weather resulting in a later start to the garden season. The declines were partially offset by increased

sales in our Wild Bird business due to the colder weather. Garden branded sales decreased $7 million, and sales of other manufacturers’

products decreased $29 million.

### Gross Profit

Gross profit for the six months ended March 29, 2025 increased $11.1 million, or 2.4%, to $468.8 million from $457.7 million for the six

months ended March 30, 2024. Gross margin improved 170 basis points to 31.5% for the six months ended March 29, 2025 from 29.8% for

the six months ended March 30, 2024.

Both the Pet and Garden segments contributed to the increase in gross profit and gross margin, which was driven by productivity gains

resulting from our Cost and Simplicity program. Prior year initiatives under the program, including facility consolidations, productivity

initiatives and the exit of lower margin business have positively impacted the gross margin as well as moderating inflation.

On a non-GAAP basis, which excludes the impact of the charges related to facility closures in the second quarter of fiscal 2025 and

fiscal 2024, gross profit for the six months ended March 29, 2025 increased $12.9 million, or 2.8%, to $473.2 million from $460.3 million for

the six months ended March 30, 2024. Non-GAAP gross margin increased 180 basis points to 31.8% for the six months ended March 29,

2025 from 30.0% for the six months ended March 30, 2024.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased $8.4 million, or 2.4%, to $347.5 million for the six months ended March 29,

2025 from $355.9 million for the six months ended March 30, 2024. As a percentage of net sales, selling, general and administrative

25

expenses increased to 23.3% for the six months ended March 29, 2025 from 23.2% for the comparable prior year six-month period.

Decreased selling, general and administrative expenses in both Garden and corporate were partially offset by increased expense in Pet.

Selling and delivery expense increased $2.7 million, or 1.8%, to $154.4 million for the six months ended March 29, 2025 from $151.7

million for the six months ended March 30, 2024. The increase was in the Pet segment and due primarily to higher media and digital

marketing spend to support eCommerce sales.

Warehouse and administrative expense decreased $11.1 million, or 5.4%, to $193.1 million for the six months ended March 29, 2025

from $204.2 million for the six months ended March 30, 2024. Garden, Pet and corporate all contributed to the decrease in warehouse and

administrative expense. The decrease was due primarily to cost reductions resulting from prior facility closures and the exit of lower margin

business. Corporate expense decreased $0.7 million due primarily to decreased insurance and third-party expense partially offset by

increased variable compensation. Corporate expenses are included within administrative expense and relate to the costs of unallocated

executive, administrative, finance, legal, human resources, and information technology functions.

### Operating Income

Operating income increased $19.5 million, or 19.1%, to $121.3 million for the six months ended March 29, 2025 from $101.8 million for

the six months ended March 30, 2024. Our operating margin increased to 8.1% for the six months ended March 29, 2025 from 6.6% for the

six months ended March 30, 2024. Operating income increased due to a $11.1 million increase in gross profit and a 170 basis point

improvement in gross margin, and an $8.4 million decrease in selling, general and administrative expense.

Pet operating income increased $5.8 million, or 5.5%, to $111.9 million for the six months ended March 29, 2025 from $106.1 million

for the six months ended March 30, 2024. Pet operating income increased due to an increase in gross profit and gross margin, partially

offset by an increase in selling, general and administrative expense.

Garden operating income increased $13.0 million to $61.2 million for the six months ended March 29, 2025 from $48.2 million for the

six months ended March 30, 2024. Garden operating income increased due to an increase in gross profit and gross margin and lower

selling, general and administrative expenses.

Corporate operating expense decreased $0.7 million to $51.7 million in the current six-month period from $52.4 million in the

comparable fiscal 2024 period due primarily to decreased insurance and third-party expense partially offset by increased variable

compensation.

### Net Interest Expense

Net interest expense for the six months ended March 29, 2025 decreased $4.1 million, or 19.3%, to $17.1 million from $21.2 million for

the six months ended March 30, 2024. The decrease in net interest expense was due to increased interest income resulting from higher

cash balances during the current six-month period. Debt outstanding as of March 29, 2025 was $1,190.8 million compared to $1,189.3 million

as of March 30, 2024.

### Other Income (Expense)

Other income (expense) decreased $1.8 million to an expense of $1.0 million for the six months ended March 29, 2025, from income

of $0.8 million for the six months ended March 30, 2024. The decrease in other income was due primarily to foreign currency losses in the

current six-month period as compared to foreign currency gains in the prior year six-month period.

### Income Taxes

Our effective income tax rate was 23.5% for the six-month period ended March 29, 2025 compared to 22.4% for the six-month period

ended March 30, 2024. The increase in our effective income tax rate was due primarily to a smaller tax benefit from stock compensation

compared to the prior six-month period.

### Net Income and Earnings Per Share

Our net income for the six months ended March 29, 2025 was $77.6 million, or $1.19 per diluted share, compared to $62.4 million, or

$0.93 per diluted share, for the six months ended March 30, 2024.

On a non-GAAP basis, net income for the six-month period ended March 29, 2025 was $81.7 million or $1.25 per diluted share,

compared to $66.5 million, or $0.99 per diluted share, for the six-month period ended March 30, 2024.

26

### Use of Non-GAAP Financial Measures

We report our financial results in accordance with GAAP. However, to supplement the financial results prepared in accordance with

GAAP, we use non-GAAP financial measures including non-GAAP net income and diluted net income per share, non-GAAP operating

income, and adjusted EBITDA. Management uses these non-GAAP financial measures that exclude the impact of specific items (described

below) in making financial, operating and planning decisions and in evaluating our performance. Also, Management believes that these non-

GAAP financial measures may be useful to investors in their assessment of our ongoing operating performance and provide additional

meaningful comparisons between current results and results in prior operating periods. While Management believes that non-GAAP

measures are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be

read in conjunction with those GAAP results.

Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and

amortization and stock-based compensation expense (or operating income plus depreciation and amortization expense and stock-based

compensation expense). Adjusted EBITDA further excludes one-time charges related to facility closures. We present adjusted EBITDA

because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business

and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluations.

Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other

income statement measures prepared in accordance with GAAP. We believe that adjusted EBITDA is frequently used by investors, securities

analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results.

Other companies may calculate adjusted EBITDA differently and it may not be comparable.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in

accordance with GAAP are shown in the tables below.

Non-GAAP financial measures reflect adjustments based on the following items:

- Facility closures: we have excluded the charges related to our decision to close distribution and manufacturing facilities as they

represent infrequent transactions that impact the comparability between operating periods. We believe these exclusions

supplement the GAAP information with a measure that may be useful to investors in assessing the sustainability of our operating

performance.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of

providing useful supplemental information to investors and management.

1\. During the second quarter of fiscal 2025, we recognized incremental expense of $5.3 million in the consolidated statement of

operations, related to the decision to wind-down our operations in the U.K. and the related facility there as we move to a direct-export

model.

2\. During the second quarter of fiscal 2024, we recognized incremental expense of $5.3 million in the consolidated statement of

operations, from the closure of a manufacturing facility in Chico, California, and the consolidation of our Southeast distribution

network.

*(in thousands, except per share amounts)*

| Net Income and Diluted Net Income Per Share Reconciliation |  | GAAP to Non-GAAP Reconciliation Three Months Ended March 29, 2025 | March 30, 2024 | Six Months Ended March 29, 2025 | March 30, 2024 |
| --- | --- | ---: | ---: | ---: | ---: |
| GAAP net income attributable to Central Garden & Pet Company |  | $63,633 | $61,987 | $77,642 | $62,417 |
| Facility closures | (1)(2) | 5,339 | 5,270 | 5,339 | 5,270 |
| Tax effect of facility closures & business exit |  | (1,255) | (1,233) | (1,255) | (1,233) |
| Non-GAAP net income attributable to Central Garden & Pet Company |  | $67,717 | $66,024 | $81,726 | $66,454 |
| GAAP diluted net income per share |  | $0.98 | $0.93 | $1.19 | $0.93 |
| Non-GAAP diluted net income per share |  | $1.04 | $0.99 | $1.25 | $0.99 |
| Shares used in GAAP and non-GAAP diluted net earnings per share calculation |  | 64,879 | 66,831 | 65,171 | 66,815 |

27

*(in thousands)*

| Operating Income Reconciliation | GAAP to Non-GAAP Reconciliation Three Months Ended March 29, 2025 GAAP | Facility closure(1) | Non-GAAP | Six Months Ended March 29, 2025 GAAP | Facility closure(1) | Non-GAAP |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net sales | $833,537 | $— | $833,537 | $1,489,973 | $— | $1,489,973 |
| Cost of goods sold and occupancy | 560,454 | 4,413 | 556,041 | 1,021,191 | 4,413 | 1,016,778 |
| Gross profit | $273,083 | $(4,413) | $277,496 | $468,782 | $(4,413) | $473,195 |
| Selling, general and administrative expenses | 179,759 | 926 | 178,833 | 347,466 | 926 | 346,540 |
| Income from operations | $93,324 | $(5,339) | $98,663 | $121,316 | $(5,339) | $126,655 |
| Gross margin | 32.8% |  | 33.3% | 31.5% |  | 31.8% |
| Operating margin | 11.2% |  | 11.8% | 8.1% |  | 8.5% |

*(in thousands)*

| Operating Income Reconciliation | GAAP to Non-GAAP Reconciliation Three Months Ended March 30, 2024 GAAP | Facility closures(2) | Non-GAAP | Six Months Ended March 30, 2024 GAAP | Facility closures(2) | Non-GAAP |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net sales | $900,090 | $— | $900,090 | $1,534,623 | $— | $1,534,623 |
| Cost of goods sold and occupancy | 621,210 | 2,527 | 618,683 | 1,076,898 | 2,527 | 1,074,371 |
| Gross profit | $278,880 | $(2,527) | $281,407 | $457,725 | $(2,527) | $460,252 |
| Selling, general and administrative expenses | 185,433 | 2,743 | 182,690 | 355,866 | 2,743 | 353,123 |
| Income from operations | $93,447 | $(5,270) | $98,717 | $101,859 | $(5,270) | $107,129 |
| Gross margin | 31.0% |  | 31.3% | 29.8% |  | 30.0% |
| Operating margin | 10.4% |  | 11.0% | 6.6% |  | 7.0% |

*(in thousands)*

| Pet Segment Operating Income Reconciliation |  | GAAP to Non-GAAP Reconciliation Three Months Ended March 29, 2025 | March 30, 2024 | Six Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: | ---: | ---: | ---: |
| GAAP operating income |  | $60,614 | $62,659 | $111,871 | $106,047 |
| Facility closure | (1) | 5,339 | — | 5,339 | — |
| Non-GAAP operating income |  | $65,953 | $62,659 | $117,210 | $106,047 |
| GAAP operating margin |  | 13.4% | 13.0% | 12.7% | 11.9% |
| Non-GAAP operating margin |  | 14.5% | 13.0% | 13.3% | 11.9% |

*(in thousands)*

| Garden Segment Operating Income Reconciliation |  | GAAP to Non-GAAP Reconciliation Three Months Ended March 29, 2025 | March 30, 2024 | Six Months Ended March 29, 2025 | March 30, 2024 |
| --- | ---: | ---: | ---: | ---: | ---: |
| GAAP operating income |  | $58,731 | $57,066 | $61,154 | $48,180 |
| Facility closure | (2) | — | 5,270 | — | 5,270 |
| Non-GAAP operating income |  | $58,731 | $62,336 | $61,154 | $53,450 |
| GAAP operating margin |  | 15.5% | 13.6% | 10.0% | 7.5% |
| Non-GAAP operating margin |  | 15.5% | 14.8% | 10.0% | 8.3% |

28

*(in thousands)*

| Adjusted EBITDA Reconciliation |  | GAAP to Non-GAAP Reconciliation Three Months Ended March 29, 2025 Pet | Garden | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet Company |  | $— | $— | $— | $63,633 |
| Interest expense, net |  | — | — | — | 9,358 |
| Other income |  | — | — | — | (744) |
| Income tax expense |  | — | — | — | 19,903 |
| Net income attributable to noncontrolling interest |  | — | — | — | 1,174 |
| Income (loss) from operations |  | 60,614 | 58,731 | (26,021) | 93,324 |
| Depreciation & amortization |  | 9,498 | 10,443 | 705 | 20,646 |
| Noncash stock-based compensation |  | — | — | 4,018 | 4,018 |
| Facility closure | (1) | 5,339 | — | — | 5,339 |
| Adjusted EBITDA |  | $75,451 | $69,174 | $(21,298) | $123,327 |

29

*(in thousands)*

| Adjusted EBITDA Reconciliation |  | GAAP to Non-GAAP Reconciliation Three Months Ended March 30, 2024 Pet | Garden | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet Company |  | $— | $— | $— | $61,987 |
| Interest expense, net |  | — | — | — | 11,473 |
| Other expense |  | — | — | — | 171 |
| Income tax expense |  | — | — | — | 19,134 |
| Net income attributable to noncontrolling interest |  | — | — | — | 682 |
| Income (loss) from operations |  | 62,659 | 57,066 | (26,278) | 93,447 |
| Depreciation & amortization |  | 11,124 | 11,014 | 674 | 22,812 |
| Noncash stock-based compensation |  | — | — | 2,907 | 2,907 |
| Facility closures | (2) | — | 5,270 | — | 5,270 |
| Adjusted EBITDA |  | $73,783 | $73,350 | $(22,697) | $124,436 |

*(in thousands)*

| Adjusted EBITDA Reconciliation |  | GAAP to Non-GAAP Reconciliation Six Months Ended March 29, 2025 Pet | Garden | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet Company |  | $— | $— | $— | $77,642 |
| Interest expense, net |  | — | — | — | 17,088 |
| Other expense |  | — | — | — | 973 |
| Income tax expense |  | — | — | — | 24,267 |
| Net income attributable to noncontrolling interest |  | — | — | — | 1,346 |
| Income (loss) from operations |  | 111,871 | 61,154 | (51,709) | 121,316 |
| Depreciation & amortization |  | 19,578 | 21,574 | 1,428 | 42,580 |
| Noncash stock-based compensation |  | — | — | 9,528 | 9,528 |
| Facility closure | (1) | 5,339 | — | — | 5,339 |
| Adjusted EBITDA |  | $136,788 | $82,728 | $(40,753) | $178,763 |

*(in thousands)*

| Adjusted EBITDA Reconciliation |  | GAAP to Non-GAAP Reconciliation Six Months Ended March 30, 2024 Pet | Garden | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet Company |  | $— | $— | $— | $62,417 |
| Interest expense, net |  | — | — | — | 21,180 |
| Other income |  | — | — | — | (822) |
| Income tax expense |  | — | — | — | 18,265 |
| Net income attributable to noncontrolling interest |  | — | — | — | 819 |
| Income (loss) from operations |  | 106,047 | 48,180 | (52,368) | 101,859 |
| Depreciation & amortization |  | 21,922 | 22,020 | 1,415 | 45,357 |
| Noncash stock-based compensation |  | — | — | 8,927 | 8,927 |
| Facility closures | (2) | — | 5,270 | — | 5,270 |
| Adjusted EBITDA |  | $127,969 | $75,470 | $(42,026) | $161,413 |

### Inflation

Our revenues and margins are dependent on various economic factors, including fluctuating rates of inflation, energy costs, interest

rates, and currencies and consumer attitudes toward discretionary spending. Inflation moderated in fiscal 2024 and this has continued into

30

fiscal 2025. We have benefited from lower cost inventory and significant productivity gains resulting in improved margins. The imposition of

tariffs and a global trade war, however, could result in higher inflation as the year progresses.

### Weather and Seasonality

Our sales of lawn and garden products are impacted by weather conditions in the different markets we serve. Our Garden segment’s

business is highly seasonal. In fiscal 2024, approximately 66% of our Garden segment’s net sales and 59% of our total net sales occurred

during our second and third fiscal quarters. Substantially all of the Garden segment’s operating income is typically generated in this period.

### Liquidity and Capital Resources

We have financed our growth through a combination of cash generated from operations, bank borrowings, supplier credit, and sales of

equity and debt securities.

Our business is seasonal, and our working capital requirements and capital resources track closely to this seasonal pattern. Generally,

during the first fiscal quarter, accounts receivable reach their lowest level while inventory, accounts payable and short-term borrowings begin

to increase. During the second fiscal quarter, receivables, accounts payable and short-term borrowings increase, reflecting the build-up of

inventory and related payables in anticipation of the peak lawn and garden selling season. During the third fiscal quarter, inventory levels

remain relatively constant while accounts receivable peak and short-term borrowings start to decline as cash collections are received during

the peak selling season. During the fourth fiscal quarter, inventory levels are at their lowest, and accounts receivable and payables are

substantially reduced through conversion of receivables to cash.

We service two broad markets: pet supplies and lawn and garden supplies. Our pet supplies businesses have a year round selling

cycle with a slight degree of seasonality. As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our

lawn and garden businesses are highly seasonal with approximately 66% of our Garden segment’s net sales occurring during the second and

third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods. To

encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended

credit terms and/or promotional discounts.

### Operating Activities

Net cash used by operating activities increased by $21.4 million, from $94.3 million for the six months ended March 30, 2024, to

$115.7 million for the six months ended March 29, 2025. The increase in cash used by operating activities was due primarily to changes in

our working capital accounts for the six-month period ended March 29, 2025, as compared to the prior year period, primarily increased

accounts receivable and inventory as well as decreased accrued expenses, all partially offset by increased accounts payable.

### Investing Activities

Net cash used in investing activities decreased $60.1 million, from $80.3 million for the six months ended March 30, 2024 to $20.2

million during the six months ended March 29, 2025. The decrease in cash used in investing activities was due primarily to acquisition activity

in the prior year and decreased capital expenditures in the current year.

### Financing Activities

Net cash used by financing activities increased $86.6 million, from $13.2 million for the six months ended March 30, 2024, to $99.7

million for the six months ended March 29, 2025. The increase in cash used by financing activities during the current year was due primarily

to increased open market purchases of our common stock as compared to the prior year. During the six months ended March 29, 2025, we

repurchased approximately 2.1 million shares of our non-voting Class A common stock (CENTA) on the open market at an aggregate cost of

approximately $63.2 million, or approximately $30.75 per share, and approximately 0.9 million shares of our voting common stock (CENT) on

the open market at an aggregate cost of approximately $30.2 million, or approximately $35.28 per share. During the six months ended March

30, 2024, we repurchased approximately 0.1 million shares of our non-voting Class A common stock (CENTA) on the open market at an

aggregate cost of approximately $1.4 million, or approximately $28.75 per share.

We expect that our principal sources of funds will be cash generated from our operations and, if necessary, borrowings under our $750

million Credit Facility. Based on our anticipated cash needs, availability under our Credit Facility and the scheduled maturity of our debt, we

believe that our sources of liquidity should be adequate to meet our working capital, capital spending and other cash needs for at least the

next 12 months. However, we cannot assure you that these sources will continue to provide us with sufficient liquidity and, should we require

it, that we will be able to obtain financing on terms satisfactory to us, or at all.

We believe that cash flows from operating activities, funds available under our Credit Facility, and arrangements with suppliers will be

adequate to fund our presently anticipated working capital and capital expenditure requirements for the foreseeable future. We anticipate that

our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also

investment in our continued implementation of a scalable enterprise-wide information technology platform, will be approximately $60 million in

fiscal 2025, of which we have invested approximately $17 million through March 29, 2025.

31

As part of our growth strategy, we have acquired a number of companies in the past, and we anticipate that we will continue to

evaluate potential acquisition candidates in the future. If one or more potential acquisition opportunities, including those that would be

material, become available in the near future, we may require additional external capital. In addition, such acquisitions would subject us to the

general risks associated with acquiring companies, particularly if the acquisitions are relatively large.

### Total Debt

At March 29, 2025, our total debt outstanding was $1,190.8 million, as compared with $1,189.3 million at March 30, 2024.

### Senior Notes

### $400 million 4.125% Senior Notes due 2031

In April 2021, we issued $400 million aggregate principal amount of 4.125% senior notes due April 2031 (the "2031 Notes"). We used

a portion of the net proceeds from the offering to repay all outstanding borrowings under our Credit Facility, with the remainder used for

general corporate purposes.

We incurred approximately $6.0 million of debt issuance costs in conjunction with this issuance, which included underwriter fees and

legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2031 Notes.

The 2031 Notes require semi-annual interest payments on April 30 and October 30. The 2031 Notes are unconditionally guaranteed on

a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our Credit

Facility. The 2031 Notes were issued in a private placement under Rule 144A and will not be registered under the Securities Act of 1933.

We may redeem some or all of the 2031 Notes at any time, at our option, prior to April 30, 2026 at the principal amount plus a "make

whole" premium. We may redeem some or all of the 2031 Notes at our option, at any time on or after April 30, 2026 for 102.063%, on or after

April 30, 2027 for 101.375%, on or after April 30, 2028 for 100.688% and on or after April 30, 2029 for 100.0%, plus accrued and unpaid

interest.

The holders of the 2031 Notes have the right to require us to repurchase all or a portion of the 2031 Notes at a purchase price equal to

101% of the principal amount of the notes repurchased, plus accrued and unpaid interest, upon the occurrence of a change of control.

The 2031 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject

to certain baskets and exceptions. We were in compliance with all financial covenants as of March 29, 2025.

### $500 million 4.125% Senior Notes due 2030

In October 2020, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030 (the "2030 Notes"). We

used a portion of the net proceeds to redeem all of our outstanding 6.125% senior notes due November 2023 (the "2023 Notes") at a

redemption price of 101.531% plus accrued and unpaid interest, and to pay related fees and expenses, with the remainder used for general

corporate purposes.

We incurred approximately $8.0 million of debt issuance costs associated with this transaction, which included underwriter fees and

legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2030 Notes.

The 2030 Notes require semiannual interest payments on October 15 and April 15. The 2030 Notes are unconditionally guaranteed on

a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our Credit

Facility.

We may redeem some or all of the 2030 Notes at any time, at our option, prior to October 15, 2025 at a price equal to 100% of the

principal amount plus a “make-whole” premium. We may redeem some or all of the 2030 Notes, at our option, in whole or in part, at any time

on or after October 15, 2025 for 102.063%, on or after October 15, 2026 for 101.375%, on or after October 15, 2027 for 100.688% and on or

after October 15, 2028 for 100.0%, plus accrued and unpaid interest.

The holders of the 2030 Notes have the right to require us to repurchase all or a portion of the 2030 Notes at a purchase price equal to

101.0% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2030 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject

to certain baskets and exceptions. We were in compliance with all financial covenants as of March 29, 2025.

### $300 Million 5.125% Senior Notes due 2028

In December 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes").

We used the net proceeds from the offering to finance acquisitions and for general corporate purposes.

We incurred approximately $4.8 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and

legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

32

The 2028 Notes require semiannual interest payments on February 1 and August 1. The 2028 Notes are unconditionally guaranteed on

a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our Credit Facility.

We may redeem some or all of the 2028 Notes at our option, through December 31, 2025 for 100.854% and on or after January 1,

2026 for 100.0%, plus accrued and unpaid interest.

The holders of the 2028 Notes have the right to require us to repurchase all or a portion of the 2028 Notes at a purchase price equal to

101.0% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject

to certain baskets and exceptions. We were in compliance with all financial covenants as of March 29, 2025.

### Asset-Based Loan Facility Amendment

On December 16, 2021, we entered into a Third Amended and Restated Credit Agreement (the “Credit Agreement”). The Credit

Agreement provides for a $750 million principal amount senior secured asset-based revolving credit facility, with up to an additional $400

million principal amount available with the consent of the Lenders, as defined, if we exercise the uncommitted accordion feature set forth

therein (collectively, the “Credit Facility”). The Credit Facility matures on December 16, 2026. We may borrow, repay and reborrow amounts

under the Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full.

The Credit Facility is subject to a borrowing base that is calculated using a formula based upon eligible receivables and inventory, and

at our election, eligible real property, minus certain reserves. Proceeds of the Credit Facility will be used for general corporate purposes. Net

availability under the Credit Facility was approximately $706 million as of March 29, 2025. The Credit Facility includes a $50 million sublimit

for the issuance of standby and commercial letters of credit and a $75 million sublimit for swing loan borrowings. As of March 29, 2025, there

were no borrowings outstanding and no letters of credit outstanding under the Credit Facility. Outside of the Credit Facility, there were other

standby and commercial letters of credit of $3.0 million outstanding as of March 29, 2025.

Borrowings under the Credit Facility bear interest at a rate based on SOFR (which will not be less than 0.00%) or, at our option, the

Base Rate, plus, in either case, an applicable margin based on our usage under the Credit Facility. Base Rate is defined as the highest of (a)

the Truist prime Bank rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month SOFR plus 1.00% and (d) 0.00%. The applicable margin

for SOFR-based borrowings fluctuates between 1.00%-1.50%, and was 1.00% as of March 29, 2025, and the applicable margin for Base

Rate borrowings fluctuates between 0.00%-0.50%, and was 0.00% as of March 29, 2025. An unused line fee shall be payable quarterly in

respect of the total amount of the unutilized Lenders’ commitments and short-notice borrowings under the Credit Facility. Standby letter of

credit fees at the applicable margin on the average undrawn and unreimbursed amount of standby letters of credit are payable quarterly and

a facing fee of 0.125% is payable quarterly for the stated amount of each letter of credit. We are also required to pay certain fees to the

administrative agent under the Credit Facility. As of March 29, 2025, the interest rate applicable to Base Rate borrowings was 7.5%, and the

interest rate applicable to one-month SOFR-based borrowings was 5.3%.

We incurred approximately $2.4 million of debt issuance costs in conjunction with this transaction, which included lender fees and legal

expenses. The debt issuance costs are being amortized over the term of the Credit Facility.

The Credit Facility contains customary covenants, including financial covenants which require us to maintain a minimum fixed charge

coverage ratio of 1:1 upon triggered quarterly testing (e.g. when availability falls below certain thresholds established in the agreement),

reporting requirements and events of default. The Credit Facility is secured by substantially all assets of the borrowing parties, including (i)

pledges of 100% of the stock or other equity interest of each domestic subsidiary that is directly owned by such entity and (ii) 65% of the

stock or other equity interest of each foreign subsidiary that is directly owned by such entity, in each case subject to customary exceptions.

We were in compliance with all financial covenants under the Credit Facility as of March 29, 2025.

### Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities

Central (the "Parent/Issuer") issued $400 million of 2031 Notes in April 2021, $500 million of 2030 Notes in October 2020, and $300

million of 2028 Notes in December 2017. The 2031 Notes, 2030 Notes and 2028 Notes are fully and unconditionally guaranteed on a joint

and several senior basis by each of our existing and future domestic restricted subsidiaries (the "Guarantors") which are guarantors of our

Credit Facility. The 2031 Notes, 2030 Notes and 2028 Notes are unsecured senior obligations and are subordinated to all of our existing and

future secured debt, including our Credit Facility, to the extent of the value of the collateral securing such indebtedness. There are no

significant restrictions on the ability of the Guarantors to make distributions to the Parent/Issuer. Certain subsidiaries and operating divisions

of the Company do not guarantee the 2031, 2030 or 2028 Notes and are referred to as the Non-Guarantors.

The Guarantors jointly and severally, and fully and unconditionally, guarantee the payment of the principal and premium, if any, and

interest on the 2031, 2030 and 2028 Notes when due, whether at stated maturity of the 2031, 2030 and 2028 Notes, by acceleration, call for

redemption or otherwise, and all other obligations of the Company to the holders of the 2031, 2030 and 2028 Notes and to the trustee under

the indenture governing the 2031, 2030 and 2028 Notes (the "Guarantee"). The Guarantees are senior unsecured obligations of each

Guarantor and are of equal rank with all other existing and future senior indebtedness of the Guarantors.

33

The obligations of each Guarantor under its Guarantee shall be limited to the maximum amount as well, after giving effect to all other

contingent and fixed liabilities of such Guarantor and to any collections from or payments made by or on behalf of any other Guarantor in

respect of the obligations of such Guarantor under the guarantee not constituting a fraudulent conveyance or fraudulent transfer under

Federal or state law.

The Guarantee of a Guarantor will be released:

(1) upon any sale or other disposition of all or substantially all of the assets of that Guarantor (including by way of merger or

consolidation), in accordance with the governing indentures, to any person other than the Company;

(2) if such Guarantor merges with and into the Company, with the Company surviving such merger;

(3) if the Guarantor is designated as an Unrestricted Subsidiary; or

(4) if the Company exercises its legal defeasance option or covenant defeasance option or the discharge of the Company's obligations

under the indentures in accordance with the terms of the indentures.

The following tables present summarized financial information of the Parent/Issuer subsidiaries and the Guarantor subsidiaries. All

intercompany balances and transactions between subsidiaries under Parent/Issuer and subsidiaries under the Guarantor have been

eliminated. The information presented below excludes eliminations necessary to arrive at the information on a consolidated basis. In

presenting the summarized financial statements, the equity method of accounting has been applied to the Parent/Issuer's interests in the

Guarantor Subsidiaries. The summarized information excludes financial information of the Non-Guarantors, including earnings from and

investments in these entities.

*(in thousands)*

| Summarized Statements of Operations March 29, 2025 | Six Months Ended Parent/Issuer | Guarantors | Fiscal Year Ended September 28, 2024 Parent/Issuer | Guarantors |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $391,195 | $1,093,469 | $694,083 | $2,491,748 |
| Gross profit | $96,318 | $370,940 | $154,310 | $771,737 |
| Income (loss) from operations | $6,787 | $121,138 | $(6,164) | $189,406 |
| Equity in earnings of Guarantor subsidiaries | $99,833 | $— | $163,797 | $— |
| Net income (loss) | $(11,427) | $99,833 | $(58,047) | $163,797 |

*(in thousands)*

| Summarized Balance Sheet Information March 29, 2025 | As of Parent/Issuer | Guarantors | As of September 28, 2024 Parent/Issuer | Guarantors |
| --- | ---: | ---: | ---: | ---: |
| Current assets | $789,923 | $1,137,814 | $936,497 | $896,476 |
| Intercompany receivable from Non-guarantor subsidiaries | 81,402 | — | 76,084 | — |
| Other assets | 3,915,327 | 3,236,994 | 3,799,521 | 3,330,344 |
| Total assets | $4,786,652 | $4,374,808 | $4,812,102 | $4,226,820 |
| Current liabilities | $187,582 | $394,247 | $164,607 | $342,289 |
| Intercompany payable from Non-guarantor subsidiaries | — | 1,625 | — | 1,003 |
| Long-term debt | 1,190,598 | 126 | 1,189,655 | 154 |
| Other liabilities | 1,844,917 | 222,712 | 1,888,312 | 234,308 |
| Total liabilities | $3,223,097 | $618,710 | $3,242,574 | $577,754 |

### New Accounting Pronouncements

Refer to Footnote 1 in the notes to the condensed consolidated financial statements for new accounting pronouncements.

34

### Critical Accounting Policies, Estimates and Judgments

There have been no material changes to our critical accounting policies, estimates and assumptions or the judgments affecting the

application of those accounting policies since our Annual Report on Form 10-K for the fiscal year ended September 28, 2024.

## Market risk

As filed, 165 characters.

There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the

fiscal year ended September 28, 2024.

## Controls and procedures

As filed, 1,455 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, including our Principal Executive Officer and Principal Financial Officer, have reviewed, as of the end of the period

covered by this report, the “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and

15d-15(e)) that ensure that information relating to the Company required to be disclosed by us in the reports that we file or submit under the

Exchange Act is recorded, processed, summarized and reported in a timely and proper manner and that such information is accumulated and

communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely

decisions regarding required disclosure. Based upon this review, such officers concluded that our disclosure controls and procedures were

effective as of March 29, 2025.

### Changes in Internal Control over Financial Reporting

Our management, with the participation of our Principal Executive Officer and our Principal Financial Officer, have evaluated whether

any change in our internal control over financial reporting occurred during the second quarter of fiscal 2025. There were no changes in our

internal control over financial reporting during the quarter ended March 29, 2025 that have materially affected, or are reasonably likely to

materially affect, our internal control over financial reporting.

## Risk factors

As filed, 167 characters.

There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year

ended September 28, 2024.

35

Filed May 8, 2025.
Source: SEC EDGAR, the filing index for accession 0000887733-25-000015. Last ingested by Listed: Nov 10, 2026, 04:49 ET. No prices; not investment advice.
